This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America

Early Registration Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

Marian Nakada
VP, Venture Investments at Johnson & Johnson Innovation

Profile

As a venture investor and a member of the Greater Boston community, Marian works on many fronts to positively impact human health. Through her role with Johnson & Johnson Innovation –JJDC, Inc. (JJDC), Johnson & Johnson’s strategic venture arm, Marian leads investments in East Coast biotechs and startups seeking to solve critical healthcare needs. Marian earned her A.B. in Biology from Harvard College and Ph.D. in Pharmacology from the University of Pennsylvania. She began her career at a lab bench at Centocor, and later transitioned into research leadership and business development after the Johnson & Johnson acquisition. Marian is energized to help her portfolio companies succeed by providing more than just capital by sharing her R&D expertise and connections to Johnson & Johnson experts. She also is a Board Member of the New England Venture Capital Association and a past reviewer for the NIH Cardiovascular Sciences Pharmacology Study Section. Outside work, Marian is a Board Member at InterCity Weightlifting and a hospice volunteer. 

Speakers at this event